- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05725161
Acceptance and Commitment Therapy for Depressed Individuals Living With Spinal Cord Injury Sustained Within 5 Years
February 23, 2025 updated by: Areum Han, University of Alabama at Birmingham
Acceptance and Commitment Therapy Supplemented With Psychoeducation for Improving Mental Health of Depressed Individuals Living With Spinal Cord Injury Sustained Within 5 Years
This randomized controlled trial aims to assess effects of videoconferencing acceptance and commitment therapy (ACT) on mental health outcomes in individuals living with spinal cord injuries (SCI).
A total of 34 individuals living with SCI sustained within 5 years and experiencing depressive symptoms will be recruited and randomly assigned to either the ACT group or the wait-list control group.
The ACT group will receive 8 weekly individual ACT sessions guided by a coach through videoconferencing.
The wait-list group will receive ACT sessions after the study period ends.
We will provide psychoeducation materials related to SCI as supplemental resources to both groups.
Mental health outcomes using self-reported questionnaires will be collected at pretest, posttest, and 2-month follow-up.
Exploratory hypotheses are that the group undergoing the ACT intervention supplemented with psychoeducation will show improvements in mental health outcomes (e.g., depression) and ACT processes (e.g., psychological flexibility) at posttest and 2-month follow-up, compared to the wait-list control group provided with psychoeducation materials alone.
Interviews will be conducted at posttest to explore the participants' experiences in ACT.
Study Overview
Status
Completed
Conditions
Detailed Description
This randomized controlled trial aims to assess effects of videoconferencing acceptance and commitment therapy (ACT) on mental health outcomes in individuals living with spinal cord injuries (SCI).
A total of 34 individuals living with SCI sustained within 5 years and experiencing depressive symptoms will be recruited and randomly assigned to either the ACT group or the wait-list control group.
The ACT group will receive 8 weekly individual ACT sessions guided by a coach through videoconferencing.
The wait-list group will receive ACT sessions after the study period ends.
We will provide psychoeducation materials related to SCI as supplemental resources to both groups.
Mental health outcomes using self-reported questionnaires will be collected at pretest, posttest, and 2-month follow-up.
Exploratory hypotheses are that the group undergoing the ACT intervention supplemented with psychoeducation will show improvements in depression (primary outcome), secondary mental health outcomes (e.g., anxiety, stress, and grief), and ACT processes (e.g., psychological flexibility) at posttest and 2-month follow-up, compared to the wait-list control group provided with psychoeducation materials alone.
Interviews will be conducted at posttest to explore the participants' experiences in ACT.
Study Type
Interventional
Enrollment (Actual)
34
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Alabama
-
Birmingham, Alabama, United States, 35294
- University of Alabama at Birmingham
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- community-dwelling adults (aged 18 years or older) living with spinal cord injuries sustained within 5 years
- having at least mild depression measured by the Patient Health Questionnaire-9
- having a computer or a smartphone and internet access at home
Exclusion Criteria:
- having cognitive deficits or language barriers that might impede study participation
- having suicidal attempts within 6 months;
- having a prior experience with acceptance and commitment therapy
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Acceptance and commitment therapy (ACT) group
8 weekly ACT sessions individually guided by a trained coach through Zoom videoconferencing with psychoeducation materials provided
|
Participants assigned to the ACT group will receive 8 weekly individual ACT sessions guided by a coach for one hour per week over 8 weeks through Zoom videoconferencing with psychoeducation materials provided.
|
|
Other: Wait-list control group with psychoeducation materials provided
Care as usual with psychoeducation materials provided during the study period and ACT sessions provided after the study period ends
|
The wait-list control group will receive care as usual with psychoeducation materials provided during the study period and receive ACT sessions after the study period ends
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change from baseline to immediately after the intervention and 2 month follow-up on the Patient Health Questionnaire-9
Time Frame: Change from baseline to immediately after the intervention and 2 month follow-up
|
The Patient Health Questionnaire-9 is a 9-item questionnaire assessing depressive symptoms on a scale of 0 to 3. Scores range from 0 to 27.
Higher scores indicate greater symptomatology in depression.
|
Change from baseline to immediately after the intervention and 2 month follow-up
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change from baseline to immediately after the intervention and 2 month follow-up on the Generalized Anxiety Disorder-7
Time Frame: Change from baseline to immediately after the intervention and 2 month follow-up
|
The Generalized Anxiety Disorder-7 is a 7-item questionnaire assessing anxiety on a scale of 0 to 3. Scores range from 0 to 21.
Higher scores indicate greater anxiety.
|
Change from baseline to immediately after the intervention and 2 month follow-up
|
|
Change from baseline to immediately after the intervention and 2 month follow-up on the Perceived Stress Scale
Time Frame: Change from baseline to immediately after the intervention and 2 month follow-up
|
The Perceived Stress Scale is a 10-item questionnaire assessing stress on a scale of 0 to 4. Scores range from 0 to 40.
Higher scores indicate greater stress.
|
Change from baseline to immediately after the intervention and 2 month follow-up
|
|
Change from baseline to immediately after the intervention and 2 month follow-up on the World Health Organization Quality of Life - Psychological health component
Time Frame: Change from baseline to immediately after the intervention and 2 month follow-up
|
World Health Organization Quality of Life - Psychological health component has 6 items measuring psychological quality of life on scale of 1 to 5. Scores range from 6 to 30.
Higher scores denote higher quality of life in terms of psychological health.
|
Change from baseline to immediately after the intervention and 2 month follow-up
|
|
Change from baseline to immediately after the intervention and 2 month follow-up on the Spinal Cord Injury-Quality of Life (SCI-QOL) Grief and Loss Short form
Time Frame: Change from baseline to immediately after the intervention and 2 month follow-up
|
SCI-QOL Grief and Loss Short form has nine items assessing grief and loss due to SCI on a scale of 1 to 5. Scores range from 9 to 45, and higher scores indicate more grief and loss.
|
Change from baseline to immediately after the intervention and 2 month follow-up
|
|
Change from baseline to immediately after the intervention and 2 month follow-up on the SCI-QOL Resilience Short form
Time Frame: Change from baseline to immediately after the intervention and 2 month follow-up
|
SCI-QOL Resilience Short form has eight items assessing resilience on a scale of 1 to 5. Scores range from 8 to 40, and higher scores indicate greater resilience.
|
Change from baseline to immediately after the intervention and 2 month follow-up
|
|
Change from baseline to immediately after the intervention and 2 month follow-up on the Self-Compassion Scale- Short Form
Time Frame: Change from baseline to immediately after the intervention and 2 month follow-up
|
Self-Compassion Scale- Short Form is a 12-item self-report questionnaire assessing self-compassion on a scale of 1 to 5. Scores range from 12 to 60. Higher scores indicate higher levels of self-compassion.
|
Change from baseline to immediately after the intervention and 2 month follow-up
|
|
Change from baseline to immediately after the intervention and 2 month follow-up on the Action and Acceptance Questionnaire-II
Time Frame: Change from baseline to immediately after the intervention and 2 month follow-up
|
Action and Acceptance Questionnaire -II is a 7-item self-report questionnaire measuring psychological flexibility on a scale of 1 to 7. Scores range from 7 to 49.
Higher scores indicate poor psychological flexibility.
|
Change from baseline to immediately after the intervention and 2 month follow-up
|
|
Change from baseline to immediately after the intervention and 2 month follow-up on the Cognitive Fusion Questionnaire
Time Frame: Change from baseline to immediately after the intervention and 2 month follow-up
|
Cognitive Fusion Questionnaire -7 is a 7-item self-report questionnaire measuring cognitive fusion on scale of 1 to 7. Scores range from 7 to 49.
Higher scores indicate greater levels of cognitive fusion.
|
Change from baseline to immediately after the intervention and 2 month follow-up
|
|
Change from baseline to immediately after the intervention and 2-month follow-up on the Engaged Living Scale
Time Frame: Change from baseline to immediately after the intervention and 2 month follow-up
|
Engaged Living Scale -9 is a 9-item self-assessment instrument that measures clarity and engagement with personal values and life fulfillment on a scale of 1 to 5. The total scores range from 9 to 45, and higher scores indicate increased clarity and engagement with personal values and greater life fulfillment.
|
Change from baseline to immediately after the intervention and 2 month follow-up
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Areum Han, PhD, University of Alabama at Birmingham
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 8, 2023
Primary Completion (Actual)
February 18, 2025
Study Completion (Actual)
February 18, 2025
Study Registration Dates
First Submitted
February 2, 2023
First Submitted That Met QC Criteria
February 2, 2023
First Posted (Actual)
February 13, 2023
Study Record Updates
Last Update Posted (Actual)
March 25, 2025
Last Update Submitted That Met QC Criteria
February 23, 2025
Last Verified
February 1, 2025
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 3191
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depression
-
Massachusetts General HospitalRecruitingDepression | Depression - Major Depressive Disorder | Depression Chronic | Depression in Adults | Depression Disorders | Depression DisorderUnited States
-
University of California, San FranciscoNational Center for Complementary and Integrative Health (NCCIH)Active, not recruitingDepression Moderate | Depression Mild | Depression, TeenUnited States
-
ProgenaBiomeWithdrawnDepression | Depression, Postpartum | Depression, Anxiety | Depression Moderate | Depression Severe | Clinical Depression | Depression in Remission | Depression, Endogenous | Depression ChronicUnited States
-
Sorlandet Hospital HFUniversity of Oslo; Karolinska Institutet; Australian Catholic University; Helse...RecruitingAnxiety | Anxiety Depression | Depression Anxiety Disorder | Depression - Major Depressive DisorderNorway
-
Lipocine Inc.CompletedDepression, Postpartum | Postnatal Depression | Peripartum Depression | Depression, Post-Partum | Postpartum Depression (PPD) | Post-Natal DepressionUnited States
-
Washington University School of MedicineCompletedTreatment Resistant Depression | Late Life Depression | Geriatric Depression | Refractory Depression | Therapy-Resistant DepressionUnited States, Canada
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Vituity PsychiatryActive, not recruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Kolby Walker, DO; Brittany KimbleRecruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
University of CincinnatiNational Center for Complementary and Integrative Health (NCCIH)RecruitingMild DepressionUnited States
-
University of MinnesotaCompletedDepression SymptomsUnited States
Clinical Trials on Acceptance and commitment therapy (ACT)
-
Anne Roche, MACompletedQuality of Life | AgingUnited States
-
VA Office of Research and DevelopmentUniversity of Alabama, TuscaloosaCompletedPsychological StressUnited States
-
Belfast Health and Social Care TrustQueen's University, Belfast; Trauma and Orthopaedics Research CharityNot yet recruitingKnee Osteoarthritis | Total Knee ArthroplastyUnited Kingdom
-
St. Olavs HospitalNorwegian University of Science and TechnologyRecruitingPost-Concussion Syndrome | Post-Traumatic HeadacheNorway
-
Indiana UniversityRegenstrief Institute, Inc.CompletedAnxiety | Anxiety Disorders and Symptoms | Caregiver BurnoutUnited States
-
Central Finland Hospital DistrictUniversity of Jyvaskyla; Finnish Diabetes AssociationCompleted
-
King's College Hospital NHS TrustKing's College London; Barts & The London NHS Trust; University Hospital Southampton... and other collaboratorsCompleted
-
University of California, San FranciscoCompletedCancer RecurrenceUnited States
-
King's College LondonGuy's and St Thomas' NHS Foundation TrustRecruiting
-
University of Alabama at BirminghamWithdrawnDepression | Stroke | Stress | AnxietyUnited States